Stay updated with breaking news from Guys Formula. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Galectin Therapeutics (NASDAQ:GALT – Get Free Report) was downgraded by StockNews.com from a “hold” rating to a “sell” rating in a research report issued on Wednesday. Separately, HC Wainwright reissued a “buy” rating and set a $11.00 price target on shares of Galectin Therapeutics in a report on Tuesday, April 9th. Check Out Our Latest […]
StockNews.com upgraded shares of Galectin Therapeutics (NASDAQ:GALT – Free Report) from a sell rating to a hold rating in a report published on Tuesday. Separately, HC Wainwright reissued a buy rating and set a $11.00 target price on shares of Galectin Therapeutics in a research note on Tuesday, April 9th. Get Our Latest Stock Analysis […]
StockNews.com upgraded shares of Galectin Therapeutics (NASDAQ:GALT – Free Report) from a sell rating to a hold rating in a report released on Tuesday morning. Separately, HC Wainwright restated a buy rating and set a $11.00 price objective on shares of Galectin Therapeutics in a report on Tuesday, April 9th. View Our Latest Report on […]
IFM Investors Pty Ltd trimmed its position in shares of Owens Corning (NYSE:OC – Free Report) by 1.8% during the first quarter, HoldingsChannel.com reports. The firm owned 26,717 shares of the construction company’s stock after selling 503 shares during the period. IFM Investors Pty Ltd’s holdings in Owens Corning were worth $4,456,000 at the end […]
Galectin Therapeutics Inc. (NASDAQ:GALT – Get Free Report) major shareholder James C. Czirr sold 21,323 shares of the business’s stock in a transaction that occurred on Monday, April 22nd. The stock was sold at an average price of $3.06, for a total value of $65,248.38. Following the completion of the transaction, the insider now owns […]